Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Molecular targets and related treatments

Checkpoint inhibitors and Pi3K inhibitors

Date

23 Oct 2023

Session

Molecular targets and related treatments

Topics

Tumour Immunology;  Targeted Therapy;  Molecular Oncology;  Immunotherapy

Tumour Site

Prostate Cancer

Presenters

Niven Mehra

Authors

N. Mehra

Author affiliations

  • Medical Oncology Department, Radboud University Medical Center, Nijmegen, 6525 GA - Nijmegen/NL

Resources

This content is available to ESMO members and event participants.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.